CO [Chinard Bloodrp] 6-K: Execution VersionNVERTIBLE NOTE PURCHASE among CHINARD BLOODRPORATION andR
[Execution VersionNVERTIBLE NOTE PURCHASE among CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITEDted April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page Section 1 2 Section 2] [SENIORNVERTIBLE NOTE SECURITIES ACT CHINARD BLOODRPORATION 7% SENIORNVERTIBLE NOTE Original Principal Amount: US$65,000,000 Holder Principal and Issuancete and Note Notes Other Notes Registration Rightsreement FOR VALUE RECEIVED, Chinard Bloodrporation, an exemptedmpany with limited liabilityorporated in theyman Islands (thempany), hereby promises to pay to the order ofR China Healthcare Investment Limited or registeredsigns (the] [EXECUTIONPY REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITED April 27ted Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THISREEMENT] [DIRECTOR INDEMNIFICATIONREEMENT between CHINARD BLOODRPORATION and JULIAN J. WOLHARDTted April 27, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTSntents Page 1. Interpretation 1 2. Indemnity 3 3. Limitations on indemnity] [Executionpy INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENTreementR CHINA HEALTHCARE INVESTMENT LIMITED InvestorRmpany This INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENT,ted of April 27, 2012 (thismpany IndemnificationreementR Indemnified Parties WHEREAS, thempany has entered into anvertible Note Purchasereementted of April 12, 2012 (the] [Chinard Bloodrporation Announcesmpletion of $65 Millionnvertible Debt Financing withR HONG KONG, China, April 27, 2012 Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood banking operator in China, today announced that it has successfully closed a US$65 millionnvertible debt financing with funds affiliated withR China Growth Fund L.P., a China-focused investment fund managed]